Convention Center Drug Inc is categorized under Visiting Nurse Services in Las Vegas, NV and active since 1986.
Convention Center Drug Inc was established in 1986, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Visiting Nurse Services business, which does work in the B2C market, and is classified as a Visiting Nurse Services, under code number 621610 by the NAICS.
If you are seeking more information, feel free to contact Ronald Memo at the company’s single location by writing to 3900 West Charleston Boulevard, Las Vegas, Nevada NV 89102 or by phoning (702) 258-0011. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Convention Center Drug Inc |
| Contact Person: | Ronald Memo |
| Address: | 3900 West Charleston Boulevard, Las Vegas, Nevada 89102 |
| Phone Number: | (702) 258-0011 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1986 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Visiting Nurse Services |
| SIC Code: | 8082 |
| NAICS Code: | 621610 |
| Share This Business: |
Convention Center Drug Inc was started in 1986 to provide professional Visiting Nurse Services under the SIC code 8082 and NAICS code 621610. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Ronald Memo for inquiries that concern Convention Center Drug Inc by calling the company number (702) 258-0011, as your correspondence is most welcome. Additionally, the physical location of the single location of Convention Center Drug Inc can be found at the coordinates 36.159167,-115.193785 as well as the street address 3900 West Charleston Boulevard in Las Vegas, Nevada 89102.
For its online presence, you may visit Convention Center Drug Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.